Lion TCR Pte. Ltd.
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC (NCT05195294) | Lion TCR Pte. Ltd. | 2025-03-01 |
| Redirected HBV-Specific T Cells in Patients With HBV-related HCC (SAFE-T-HBV) (NCT04745403) | Lion TCR Pte. Ltd. | 2022-05-20 |
| A Study of LioCyx in Patient With Recurrent HBV-related HCC Post Liver Transplantation (NCT03634683) | Lion TCR Pte. Ltd. | 2018-08-01 |
| A Study of TCR-Redirected T Cell Infusion to Prevent Hepatocellular Carcinoma Recurrence Post Liver Transplantation (NCT02686372) | Lion TCR Pte. Ltd. | 2018-05-16 |
Track Lion TCR Pte. Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.